Trust Company of Toledo’s BioMarin Pharmaceuticals BMRN Stock Holding History

Trust Company of Toledo’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-300	Closed	-$16.2K	–	776
2025 Q3	$16.2K	Hold	300	–	–	﹤0.01%	567
2025 Q2	$16.5K	Buy	+300	New	+$17.7K	﹤0.01%	558

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Trust Company of Toledo's BMRN Position: Q4 2025 in Review

Trust Company of Toledo sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2025, closing a stake of 300 shares — an estimated $16.2K sold.

Trust Company of Toledo first reported a position in BMRN in Q2 2025 and held it in 2 quarters. The position peaked at $16.5K in Q2 2025. 539 funds tracked by Wall St. Rank hold BMRN as of Q4 2025.

Trust Company of Toledo reported no remaining BioMarin Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Trust Company of Toledo sold 300 BioMarin Pharmaceuticals shares in Q4 2025, an estimated $16.2K.
Trust Company of Toledo first reported a position in BioMarin Pharmaceuticals in Q2 2025 and held it in 2 quarters.
Trust Company of Toledo's BioMarin Pharmaceuticals position peaked at $16.5K in Q2 2025.
539 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2025.

Based on Trust Company of Toledo's 13F filing for Q4 2025, filed 20 Jan 2026.